Trending at Lumira Ventures

Opsens Reports FY2019 Revenues of $32.8M, up 36%

Jennifer Schram Opsens, Portfolio News

QUEBEC CITY, Quebec – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for 2019. Highlights For the Quarter and The Year Record consolidated revenues at $32.8 M for FY2019 compared with $24.1 M for FY2018, a 36% increase; Fractional Flow …

Zymeworks Reports Q3 2019 Financial Results

Jennifer Schram Portfolio News, Zymeworks

“We recently presented data on our lead asset, ZW25, at two major medical conferences that pave the way for registration-enabling trials in second-line biliary tract cancer (BTC) with single agent ZW25 and in first-line gastroesophageal adenocarcinoma (GEA) with ZW25 in …

G1 Therapeutics Reports Q3 2019 Financials

Jennifer Schram G1 Therapeutics, Portfolio News

RESEARCH TRIANGLE PARK, N.C. (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today provided a corporate and financial update for the third quarter ended September 30, 2019. Review the full filling here. “Based on written feedback from the FDA following our pre-NDA meeting …